Showing results (841-850 of 1,251) with videos related to
Sort By:
Pageof 126
Cancer Treatment and Research Communications|March 27, 2026
Rethinking local therapy in de novo metastatic breast cancer: the emerging role of radiotherapyValentina Zagardo, Antonio Pontoriero, Giuseppina Scandurra, et al.Cancer Treatment and Research Communications|April 12, 2026
Integrating the Silva pattern into clinical practice: a prognostic tool for tailoring surgery and adjuvant therapy in cervical adenocarcinomaXinmei Wang, Juan Xu, Hongyuan Zhang, et al.Cancer Treatment and Research Communications|April 19, 2026
Human microbiome influence on head and neck cancerVandhana Vijayakumar, Thirumalaikumaran Rathinam, Sakthi Sanjana Deenadhayalan, et al.Cancer Treatment and Research Communications|April 19, 2026
The role of dietary components in upper gastrointestinal cancers: A narrative reviewZiba Asheri, Ahmadreza Kolahi, Mahdi Amirpour, et al.Cancer Treatment and Research Communications|April 7, 2026
miR-155 and the orchestration of cell-death evasion and chemoresistance in cancer: Isoform-specific mechanisms and therapeutic opportunitiesSaeb Younis Abdul-Rahman, Abdulkareem Shareef, S Renuka Jyothi, et al.Cancer Treatment and Research Communications|September 2, 2023
Implementing a mailed stool sample screening program in clinics providing care for an underserved Hispanic populationNikit Venishetty, Jessica Calderon-Mora, Navkiran K Shokar, et al.Cancer Treatment and Research Communications|September 15, 2023
Cardiotoxicity in breast cancer treatment: Causes and mitigationDeepthi Valiyaveettil, Deepa Joseph, Monica MalikCancer Treatment and Research Communications|April 5, 2026
PARK7 (DJ-1) indicates favorable prognosis and correlates with estrogen-receptor status and Nε-carboxymethyl-lysine (CML) accumulation in breast cancerNorbert Nass, Susanne Sprung, Atanas Ignatov, et al.Cancer Treatment and Research Communications|April 9, 2026
Feasibility of quality indicators to assess the prevalence of guideline adherence in a german cohort of patients with advanced or metastatic breast cancer: Results of the BRE-BY-MED studyLilly Sophia Brandstetter, Anna Grau, Max Müller-Reiter, et al.Cancer Treatment and Research Communications|March 21, 2026
Towards identification of novel inhibitors of EGFR mutants through in-silico approachPallavi Khodlan, Rajdeep Chakraborty, Tabarak Malik, et al.Pageof 126